Veppanu Tablet, Film Coated
Product Images NDC 71332-008

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Veppanu (NDC 71332-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rigel Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vep100 (100mg)

VEPPANU 100 mg film coated tablets label showing the proprietary name VEPPANU with active ingredient vepdegestrant. The label indicates 30 tablets per package, oral route, and is manufactured by Rigel Pharmaceuticals, Inc. It states prescription use (Rx only).*

FDA Label Image

Vepp200 (200mg)

VEPPANU 200 mg film-coated tablets label showing the proprietary name VEPPANU and the generic name vepdegestrant. The label indicates oral route and prescription use only. It also shows the labeler as Rigel Pharmaceuticals, Inc. The packaging specifies a quantity of 30 tablets.*

FDA Label Image

Figure1 (Fig1)

A Kaplan-Meier survival curve plot showing the probability of progression-free survival (PFS) over time in months from randomization, comparing VEPPANU to Fulvestrant. The graph includes survival curves for each treatment group and a table below indicating the number of patients at risk for both VEPPANU and Fulvestrant at various time points up to approximately 19 months.*

FDA Label Image

Chemstructure (Structure)

Chemical structure of vepdegestrant, the active ingredient in VEPPANU, a prescription drug. The structure consists of multiple aromatic rings, nitrogen atoms in heterocyclic rings, and functional groups including hydroxyl and carbonyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.